ArticleGut2017

Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma.

Julien Bollard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.